Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'beta-amyloid' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 2505 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Blauw, GJ; Bollen, ELEM; van Buchem, MA; Westendorp, RGJ
      Dementia at old age: a clinical end-point of atherosclerotic disease

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    2. Small, DH; Mok, SS; Bornstein, JC
      Alzheimer's disease and AP toxicity: from top to bottom

      NATURE REVIEWS NEUROSCIENCE
    3. Ferri, KF; Kroemer, G
      Organelle-specific initiation of cell death pathways

      NATURE CELL BIOLOGY
    4. Friedhoff, LT; Cullen, EI; Geoghagen, NSM; Buxbaum, JD
      Treatment with controlled-release lovastatin decreases serum concentrations of human beta-amyloid (A beta) peptide

      INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
    5. McGrath, LT; McGleenon, BM; Brennan, S; McColl, D; McIlroy, S; Passmore, AP
      Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde

      QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
    6. de Ceballos, ML; Brera, B; Fernandez-Tome, MP
      beta-Amyloid-induced cytotoxicity, peroxide generation and blockade of glutamate uptake in cultured astrocytes

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    7. Mikros, E; Benaki, D; Humpfer, E; Spraul, M; Loukas, S; Stassinopoulou, CI; Pelecanou, M
      High-resolution NMR spectroscopy of the beta-amyloid(1-28) fibril typical for Alzheimer's disease

      ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
    8. Nicosia, F; Alberici, A; Benussi, L; Gasparini, L; Ghidoni, R; Mazzoli, F; Zanetti, O; Frisoni, GB; Geroldi, C; Binetti, G
      Analysis of alpha-2-macroglobulin-2 allele as a risk factor in Alzheimer'sdisease

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    9. Sjogren, M; Davidsson, P; Gottfries, J; Vanderstichele, H; Edman, A; Vanmechelen, E; Wallin, A; Blennow, K
      The cerebrospinal fluid levels of tau, growth-associated protein-43 and soluble amyloid precursor protein correlate in Alzheimer's disease, reflecting a common pathophysiological process

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    10. Eckert, A; Oster, M; Zerfass, R; Hennerici, M; Muller, WE
      Elevated levels of fragmented DNA nucleosomes in native and activated lymphocytes indicate an enhanced sensitivity to apoptosis in sporadic Alzheimer's disease - Specific differences to vascular dementia

      DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    11. Broadley, KJ; Kelly, DR
      Muscarinic receptor agonists and antagonists

      MOLECULES
    12. Huse, JT; Doms, RW
      Neurotoxic traffic: Uncovering the mechanics of amyloid production in Alzheimer's disease

      TRAFFIC
    13. Watanabe, K; Segawa, T; Nakamura, K; Kodaka, M; Konakahara, T; Okuno, H
      Identification of the molecular interaction site of amyloid beta peptide by using a fluorescence assay

      JOURNAL OF PEPTIDE RESEARCH
    14. Nishino, S; Nishida, Y
      Oxygenation of amyloid beta-peptide (1-40) by copper(II) complex and hydrogen peroxide system

      INORGANIC CHEMISTRY COMMUNICATIONS
    15. Santiard-Baron, D; Lacoste, A; Ellouk-Achard, S; Soulie, C; Nicole, A; Sarasin, A; Ceballos-Picot, I
      The amyloid peptide induces early genotoxic damage in human preneuron NT2

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    16. Mattson, MP; Duan, W; Pedersen, WA; Culmsee, C
      Neurodegenerative disorders and ischemic brain diseases

      APOPTOSIS
    17. Owens, J
      Milking nature for Alzheimer's treatment

      DRUG DISCOVERY TODAY
    18. Rausch, DM; Davis, MR
      HIV in the CNS: Pathogenic relationships to systemic HIV disease and otherCNS diseases

      JOURNAL OF NEUROVIROLOGY
    19. Jhee, S; Shiovitz, T; Crawford, AW; Cutler, NR
      beta-amyloid therapies in Alzheimer's disease

      EXPERT OPINION ON INVESTIGATIONAL DRUGS

    20. Statine-derived tetrapeptide inhibitors of beta-secretase - Elan Pharm., Inc.: WO0077030

      EXPERT OPINION ON THERAPEUTIC PATENTS
    21. Heo, HJ; Cho, HY; Hong, BS; Kim, HK; Kim, EK; Kim, BG; Shin, DH
      Protective effect of 4 ',5-dihydroxy-3 ',6,7-trimethoxyflavone from Artemisia asiatica against A beta-indueed oxidative stress in PC12 cells

      AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
    22. Yang, DS; Serpell, LC; Yip, CM; McLaurin, J; Chrishti, MA; Horne, P; Boudreau, L; Kisilevsky, R; Westaway, D; Fraser, PE
      Assembly of Alzheimer's amyloid-beta fibrils and approaches for therapeutic intervention

      AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
    23. Van Nostrand, WE; Melchor, JP
      Disruption of pathologic amyloid beta-protein fibril assembly on the surface of cultured human cerebrovascular smooth muscle cells

      AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
    24. Nicoll, JAR; McCarron, MO
      APOE gene polymorphism as a risk factor for cerebral amyloid angiopathy-related hemorrhage

      AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
    25. Greenberg, SM; Rosand, J
      Outcome markers for clinical trials in cerebral amyloid angiopathy

      AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
    26. Kimura, N; Nakamura, S; Goto, N; Narushima, E; Hara, I; Shichiri, S; Saitou, K; Nose, M; Hayashi, T; Kawamura, S; Yoshikawa, Y
      Senile plaques in an aged Western lowland gorilla

      EXPERIMENTAL ANIMALS
    27. Hoozemans, JJM; Rozemuller, AJM; Veerhuis, R; Eikelenboom, P
      Immunological aspects of Alzheimer's disease - Therapeutic implications

      BIODRUGS
    28. Halliwell, B
      Role of free radicals in the neurodegenerative diseases - Therapeutic implications for antioxidant treatment

      DRUGS & AGING
    29. Haass, C; Steiner, H
      Protofibrils, the unifying toxic molecule of neurodegenerative disorders?

      NATURE NEUROSCIENCE
    30. Mattson, MP; Duan, WZ; Lee, J; Guo, ZH; Roth, GS; Ingram, DK; Lane, MA
      Progress in the development of caloric restriction mimetic dietary supplements

      JOURNAL OF ANTI-AGING MEDICINE
    31. Skribanek, Z; Balaspiri, L; Mak, M
      Interaction between synthetic amyloid-beta-peptide (1-40) and its aggregation inhibitors studied by electrospray ionization mass spectrometry

      JOURNAL OF MASS SPECTROMETRY
    32. Tickler, AK; Barrow, CJ; Wade, JD
      Improved preparation of amyloid-beta peptides using DBU as N-alpha-Fmoc deprotection reagent

      JOURNAL OF PEPTIDE SCIENCE
    33. Fulop, L; Penke, B; Zarandi, M
      Synthesis and fluorescent labeling of beta-amyloid peptides

      JOURNAL OF PEPTIDE SCIENCE
    34. Clippingdale, AB; Wade, JD; Barrow, CJ
      The amyloid-beta peptide and its role in Alzheimer's disease

      JOURNAL OF PEPTIDE SCIENCE
    35. Balaspiri, L; Langel, U
      Synthesis of of beta-amyloid precursor peptide and presenilin segments

      JOURNAL OF PEPTIDE SCIENCE
    36. Malin, DH; Crothers, MK; Lake, JR; Goyarzu, P; Plotner, RE; Garcia, SA; Spell, SH; Tomsic, BJ; Giordano, T; Kowall, NW
      Hippocampal injections of amyloid beta-peptide 1-40 impair subsequent one-trial/day reward learning

      NEUROBIOLOGY OF LEARNING AND MEMORY
    37. Rhodin, J; Thomas, T
      A vascular connection to Alzheimer's disease

      MICROCIRCULATION
    38. Kontush, A; Donarski, N; Beisiegel, U
      Resistance of human cerebrospinal fluid to in vitro oxidation is directly related to its amyloid-beta content

      FREE RADICAL RESEARCH
    39. Bamberger, ME; Landreth, GE
      Microglial interaction with beta-amyloid: Implications for the pathogenesis of Alzheimer's disease

      MICROSCOPY RESEARCH AND TECHNIQUE
    40. Preston, JE
      Ageing choroid plexus-cerebrospinal fluid system

      MICROSCOPY RESEARCH AND TECHNIQUE
    41. Chodobski, A; Szmydynger-Chodobska, J
      Choroid plexus: Target for polypeptides and site of their synthesis

      MICROSCOPY RESEARCH AND TECHNIQUE
    42. Spreafico, F; Barski, JJ; Farina, C; Meyer, M
      Mouse DREAM/Calsenilin/KChIP3: Gene structure, coding potential, and expression

      MOLECULAR AND CELLULAR NEUROSCIENCE
    43. Kim, HJ; Lee, WH; Yoon, CH; Jeong, JC; Nam, KS; Kim, HM; Choo, YK; Lee, MC; Kim, CH
      Bombycis corpus extract prevents amyloid-beta-induced cytotoxicity and protects superoxide dismutase activity in cultured rat astrocytes

      PHARMACOLOGICAL RESEARCH
    44. Calabrese, EJ
      Amyloid beta-peptide: Biphasic dose responses

      CRITICAL REVIEWS IN TOXICOLOGY
    45. Sun, AY; Sun, GY
      Ethanol and oxidative mechanisms in the brain

      JOURNAL OF BIOMEDICAL SCIENCE
    46. Ferrer, I; Blanco, R; Carmona, M; Ribera, R; Goutan, E; Puig, B; Rey, MJ; Cardozo, A; Vinals, F; Ribalta, T
      Phosphorylated map kinase (ERK1, ERK2) expression is associated with earlytau deposition in neurones and glial cells, but not with increased nuclearDNA vulnerability and cell death, in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration

      BRAIN PATHOLOGY
    47. Ma, XF; Ye, WL; Mei, ZT
      Change of cholinergic transmission and memory deficiency induced by injection of beta-amyloid protein into NBM of rats

      SCIENCE IN CHINA SERIES C-LIFE SCIENCES
    48. Qi, B; Qi, YP; Liu, QZ; Qu, XL
      asy and asyip: A new type of apoptosis-inducing gene

      CHINESE SCIENCE BULLETIN
    49. Steinhoff, T; Moritz, E; Wollmer, MA; Mohajeri, MH; Kins, S; Nitsch, RM
      Increased cystatin C in astrocytes of transgenic mice expressing the K670N-M671L mutation of the amyloid precursor protein and deposition in brain amyloid plaques

      NEUROBIOLOGY OF DISEASE
    50. Harkany, T; O'Mahony, S; Keijser, J; Kelly, JP; Konya, C; Borostyankoi, ZA; Gorcs, TJ; Zarandi, M; Penke, B; Leonard, BE; Luiten, PGM
      beta-amyloid((1-42))-induced cholinergic lesions in rat nucleus basalis bidirectionally modulate serotonergic innervation of the basal forebrain and cerebral cortex

      NEUROBIOLOGY OF DISEASE
    51. Pedersen, WA; McCullers, D; Culmsee, C; Haughey, NJ; Herman, JP; Mattson, MP
      Corticotropin-releasing hormone protects neurons against insults relevant to the pathogenesis of Alzheimer's disease

      NEUROBIOLOGY OF DISEASE
    52. Head, E; Azizeh, BY; Lott, IT; Tenner, AJ; Cotman, CW; Cribbs, DH
      Complement association with neurons and beta-amyloid deposition in the brains of aged individuals with down syndrome

      NEUROBIOLOGY OF DISEASE
    53. Eckert, A; Schindowski, K; Leutner, S; Luckhaus, C; Touchet, N; Czech, C; Muller, WE
      Alzheimer's disease-like alterations in peripheral cells from presenilin-1transgenic mice

      NEUROBIOLOGY OF DISEASE
    54. Zhuang, ZP; Kung, MP; Hou, C; Plossl, K; Skovronsky, D; Gur, TL; Trojanowski, JQ; Lee, VMY; Kung, HF
      IBOX(2-(4 '-dimethylaminophenyl)-6-iodobenzoxazole): a ligand for imaging amyloid plaques in the brain

      NUCLEAR MEDICINE AND BIOLOGY
    55. Kang, JH; Park, EJ; Jou, I; Kim, JH; Joe, EH
      Reactive oxygen species mediate A beta(25-35)-induced activation of BV-2 microglia

      NEUROREPORT
    56. Chauhan, VPS; Chauhan, A; Wegiel, J
      Fibrillar amyloid beta-protein forms a membrane-like hydrophobic domain

      NEUROREPORT
    57. Cedazo-Minguez, A; Huttinger, M; Cowburn, RF
      beta-VLDL protects against A beta(I-42) and apoE toxicity in human SH-SY5Yneuroblastoma cells

      NEUROREPORT
    58. Milton, NGN
      Phosphorylation of amyloid-beta at the serine 26 residue by human cdc2 kinase

      NEUROREPORT
    59. Poduslo, JF; Curran, GL
      Amyloid beta peptide as a vaccine for Alzheimer's disease involves receptor-mediated transport at the blood-brain barrier

      NEUROREPORT
    60. Thomas, T; Nadackal, TG; Thomas, K
      Aspirin and non-steroidal anti-inflammatory drugs inhibit amyloid-beta aggregation

      NEUROREPORT
    61. Laitinen, KSM; van Groen, T; Tanila, H; Venalainen, J; Mannisto, PT; Alafuzoff, I
      Brain prolyl oligopeptidase activity is associated with neuronal damage rather than beta-amyloid accumulation

      NEUROREPORT
    62. Sheng, SL; Zhao, YM; Zhao, ZW; Ji, ZJ
      beta-amyloid and its binding protein in the hippocampus of diabetic mice: effect of APP17 peptide

      NEUROREPORT
    63. Exley, C; Korchazhkina, OV
      Plasmin cleaves A beta 42 in vitro and prevents its aggregation into beta-pleated sheet structures

      NEUROREPORT
    64. Botta, L; Valli, P; Asti, A; Perin, P; Zucca, G; Racchi, M; Govoni, S; Pascale, A
      beta amyloid-induced disruption of ionic balance: studies on the isolated frog labyrinth

      NEUROREPORT
    65. Milton, NGN; Mayor, NP; Rawlinson, J
      Identification of amyloid-beta binding sites using an antisense peptide approach

      NEUROREPORT
    66. Hasegawa, H; Nakai, M; Tanimukai, S; Taniguchi, T; Terashima, A; Kawamata, T; Fukunaga, K; Miyamoto, E; Misaki, K; Mukai, H; Tanaka, C
      Microglial signaling by amyloid beta protein through mitogen-activated protein kinase mediating phosphorylation of MARCKS

      NEUROREPORT
    67. De Berardinis, MA; Ciotti, MT; Amadoro, G; Galli, C; Calissano, P
      Transfer of the apoptotic message in sister cultures of cerebellar neurons

      NEUROREPORT
    68. Lebeau, A; Esclaire, F; Rostene, W; Pelaprat, D
      Baicalein protects cortical neurons from beta-amyloid (25-35) induced toxicity

      NEUROREPORT
    69. Lukiw, WJ; Gordon, WC; Rogaev, EI; Thompson, H; Bazan, NG
      Presenilin-2 (PS2) expression up-regulation in a model of retinopathy of prematurity and pathoangiogenesis

      NEUROREPORT
    70. Zerbinatti, C; Bu, GJ
      Genetics and molecular biology - Editorial comment

      CURRENT OPINION IN LIPIDOLOGY
    71. Matsumoto, A; Itoh, K; Seki, T; Motozaki, K; Matsuyama, S
      Human brain carboxypeptidase B, which cleaves beta-amyloid peptides in vitro, is expressed in the endoplasmic reticulum of neurons

      EUROPEAN JOURNAL OF NEUROSCIENCE
    72. Bush, AI
      Therapeutic targets in the biology of Alzheimer's disease

      CURRENT OPINION IN PSYCHIATRY
    73. Schonknecht, P; Pantel, J; Schroder, J
      Quantitative magnetic resonance imaging in the diagnosis of Alzheimer's disease

      ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE
    74. Butterfield, DA; Howard, BJ; LaFontaine, MA
      Brain oxidative stress in animal models of accelerated aging and the age-related neurodegenerative disorders, Alzheimer's disease and Huntington's disease

      CURRENT MEDICINAL CHEMISTRY
    75. Pomara, N; Crandall, DT; Choi, SJ; Johnson, G; Lim, KO
      White matter abnormalities in HIV-1 infection: A diffusion tensor imaging study

      PSYCHIATRY RESEARCH-NEUROIMAGING
    76. Lewis, PA; Piper, S; Baker, M; Onstead, L; Murphy, MP; Hardy, J; Wang, R; McGowan, E; Golde, TE
      Expression of BRI-amyloid beta peptide fusion proteins: a novel method forspecific high-level expression of amyloid beta peptides

      BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
    77. Imaizumi, K; Miyoshi, K; Katayama, T; Yoneda, T; Taniguchi, M; Kudo, T; Tohyama, M
      The unfolded protein response and Alzheimer's disease

      BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
    78. Maioli, E; Torricelli, C; Santucci, A; Martelli, P; Pacini, A
      Plasma factors controlling atrial natriuretic peptide (ANP) aggregation: role of lipoproteins

      BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
    79. Janciauskiene, S
      Conformational properties of serine proteinase inhibitors (serpins) confermultiple pathophysiological roles

      BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
    80. Ramirez-Exposito, MJ; Robert-Baudouy, J; Mayas, MD; Garcia, MJ; Ramirez, M; Martinez-Martos, JM
      Acetylcholinesterase inhibitor SDZ ENA 713 (Rivastigmine) increases brain pyrrolidone carboxyl peptidase activity

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    81. Yamazaki, M; Sakura, N; Chiba, K; Mohri, T
      Prevention of the neurotoxicity of the amyloid beta protein by genipin

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    82. Galasko, D
      Biological markers and the treatment of Alzheimer's disease

      JOURNAL OF MOLECULAR NEUROSCIENCE
    83. Bertram, L; Tanzi, RE
      Dancing in the dark? The status of late-onset Alzheimer's disease genetics

      JOURNAL OF MOLECULAR NEUROSCIENCE
    84. Glabe, C
      Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease

      JOURNAL OF MOLECULAR NEUROSCIENCE
    85. Vassar, R
      The beta-secretase, BACE - A prime drug target for Alzheimer's disease

      JOURNAL OF MOLECULAR NEUROSCIENCE
    86. Thinakaran, G
      Metabolism of presenilins

      JOURNAL OF MOLECULAR NEUROSCIENCE
    87. Mattson, MP; Chan, SL
      Dysregulation of cellular calcium homeostasis in Alzheimer's disease - Badgenes and bad habits

      JOURNAL OF MOLECULAR NEUROSCIENCE
    88. Kotzbauer, PT; Trojanowski, JQ; Lee, VMY
      Lewy body pathology in Alzheimer's disease

      JOURNAL OF MOLECULAR NEUROSCIENCE
    89. Schenk, D; Games, D; Seubert, P
      Potential treatment opportunities for Alzheimer's disease through inhibition of secretases and A beta immunization

      JOURNAL OF MOLECULAR NEUROSCIENCE
    90. Brown, AM; Sheu, RKF; Mohs, R; Haroutunian, V; Blass, JP
      Correlation of the clinical severity of Alzheimer's disease with an aberration in mitochondrial DNA (antDNA)

      JOURNAL OF MOLECULAR NEUROSCIENCE
    91. Lue, LF; Rydel, R; Brigham, EF; Yang, LB; Hampel, H; Murphy, GM; Brachova, L; Yan, SD; Walker, DG; Shen, Y; Rogers, J
      Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro

      GLIA
    92. Kiuchi, Y; Isobe, Y; Kijima, H; Kajita, S; Saito, T; Fukushima, K
      Effect of basement membrane components on assembly of 3-pyroglutamylamyloid beta-protein

      NEUROSCIENCE RESEARCH COMMUNICATIONS
    93. Mager, PP
      Molecular simulation of solution conformations of the amyloid beta-peptideA beta(1-42) by a backpropagation neural network model

      MOLECULAR SIMULATION
    94. Mager, PP; Reinhardt, R; Fischer, K
      Molecular simulation to aid in the understanding of the A beta(1-42) peptide of Alzheimer's disease

      MOLECULAR SIMULATION
    95. Koudinov, AR; Koudinova, NV
      Essential role for cholesterol in synaptic plasticity and neuronal degeneration

      FASEB JOURNAL
    96. Choi, SH; Park, CH; Koo, JW; Seo, JH; Kim, HS; Jeong, SJ; Lee, JH; Kim, SS; Suh, YH
      Memory impairment and cholinergic dysfunction by centrally administered A beta and carboxyl-terminal fragment of Alzheimer's APP in mice

      FASEB JOURNAL
    97. Yazawa, H; Yu, ZX; Takeda, K; Le, Y; Gong, WH; Ferrans, VJ; Oppenheim, JJ; Li, CCH; Wang, JM
      beta amyloid peptide (A beta(42)) is internalized via the G-protein-coupled receptor FPRL1 and forms fibrillar aggregates in macrophages

      FASEB JOURNAL
    98. Tan, DX; Manchester, LC; Burkhardt, S; Sainz, RM; Mayo, JC; Kohen, R; Shohami, E; Huo, YS; Hardeland, R; Reiter, RJ
      N-1-acetyl-N-2-formyl-5-methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant

      FASEB JOURNAL
    99. Hogh, P; Knudsen, GM; Kjaer, KH; Jorgensen, OS; Paulson, OB; Waldemar, G
      Single photon emission computed tomography and apolipoprotein E in Alzheimer's disease: Impact of the epsilon 4 allele on regional cerebral blood flow

      JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY
    100. Kontush, A
      Amyloid-beta: An antioxidant that becomes a pro-oxidant and critically contributes to Alzheimer's disease

      FREE RADICAL BIOLOGY AND MEDICINE


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/06/20 alle ore 14:46:37